Loading insider details...
Beta
Latest Form 4 (Jun 29, 2026): Grant/Award of 35,000 LXEO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Lexeo Therapeutics, Inc. (LXEO) | Grant/Award | 35,000 | n/a |
| Oct 7, 2025 | scPharmaceuticals Inc. (SCPH) | Disposition to Issuer | 30,000 | n/a |
| Jun 30, 2025 | Lexeo Therapeutics, Inc. (LXEO) | Grant/Award | 25,000 | n/a |
| Jun 5, 2025 | scPharmaceuticals Inc. (SCPH) | Grant/Award | 30,000 | n/a |
| Jun 27, 2024 | Lexeo Therapeutics, Inc. (LXEO) | Grant/Award | 18,000 | n/a |
| Jun 13, 2024 | scPharmaceuticals Inc. (SCPH) | Grant/Award | 19,750 | n/a |
| Feb 6, 2024 | Lexeo Therapeutics, Inc. (LXEO) | Grant/Award | 36,000 | n/a |
| Jun 8, 2023 | scPharmaceuticals Inc. (SCPH) | Grant/Award | 17,300 | n/a |
| Jun 11, 2020 | scPharmaceuticals Inc. (SCPH) | Grant/Award | 6,124 | n/a |
| Mar 16, 2020 | IMARA Inc. (IMRA) | Conversion | 1,245,222 | n/a |